Regulatory status: Canada & US

Current as of October 2026. Rules and enforcement in this area are changing quickly. This lesson is general information, not legal advice.

A lot of buyers assume a “research use only” label puts a product in a legal grey zone. Regulators in both Canada and the US have said clearly that it doesn’t. This lesson covers what they’ve said and what it means for you.

How regulators decide what a product is

Neither Canada nor the US regulates “peptides” as one category. Regulators look at what the product is for: its intended use, how it’s taken, and what the seller says about it. They judge the whole picture: the website, the marketing, what’s bundled with it. A disclaimer on the label is only one part of that.

Canada

• Most peptides sold for performance, anti-aging or therapeutic effects are regulated as drugs under the Food and Drugs Act. Injectable peptides are treated as prescription drugs and need Health Canada authorization before they can be sold.
• Authorized drugs carry an 8-digit DIN (Drug Identification Number). A small number of peptide medicines, such as insulin products, are authorized. Many peptides commonly sold online are not.
• “Research use only” doesn’t change that. In an April 2026 advisory, Health Canada said this kind of labelling “does not make these products legal or exempt from regulatory requirements,” and that unauthorized drug products are illegal in Canada.
• Enforcement is happening. In June 2026, a court issued a permanent injunction against a Canadian online retailer of unauthorized injectable peptides.
• Health Canada’s advice to consumers: buy prescription drugs only from licensed pharmacies, check for a DIN, and report side effects.

United States

• The FDA uses the same “intended use” approach. In August 2026 it issued warning letters to five online peptide sellers and rejected their “research use only” labels. It pointed to the overall impression of each site, citing things like dosing claims, reconstitution calculators, and bacteriostatic water sold alongside the products as evidence they were intended for human use.
• Compounding is a separate channel. Licensed compounding pharmacies can only use certain bulk ingredients. In April 2026, the FDA removed 12 peptides from its list of substances raising significant safety concerns, and scheduled advisory committee review (July 2026) of several, including BPC-157. Check FDA’s current position, as the outcome may have changed since. Removal from that list does not make a peptide approved or automatically allowed for compounding.

What this means for you as a buyer

• A product sold “for research use only” has not been assessed by Health Canada or the FDA for safety, quality or effectiveness in people.
• Buying outside the pharmacy system means none of the checks a pharmacy would do are being done for you. Your own verification (the rest of Level 1) is the only check.
• Labels and disclaimers tell you nothing about legality. Authorization does.

How to check a product’s status

• Canada: search Health Canada’s Drug Product Database for the product or its DIN.
• US: search Drugs@FDA for approved drug products.
• If a product has no DIN in Canada or FDA approval in the US, it is not an authorized drug in that country.

Sources

• Health Canada, Think twice before injecting peptides bought online (April 2026)
• Gowling WLG, Peptides in Canada (September 2026)
• Arent Fox Schiff, Five peptide vendors learn “Research Use Only” is not a legal strategy (September 2026)
• Goodwin, FDA signals evolving stance on compounding of certain peptides (May 2026)

Level 1 complete. You now know how the market works, how to read the paperwork, how to vet a seller, and where the law stands. Level 2 goes deeper.